It became apparent early in the COVID-19 pandemic that people with substance use disorders were going to have an especially tough go of it. Anxiety and social isolation spiked along with infection rates, both simultaneously with reduced access to treatment resources. It was predictable, then, that data showed the already-existing opioid epidemic escalating. So, it’s alarming to learn that even in 2019 only 28% of U.S. adults and adolescents who could have benefited from treatment …
Read More









